Getty Images; Matt Ryan, MH Illustration 5 min read I NTEREST IN research investigating psychedelic drugs including psilocybin, ketamine, ibogaine, and LSD and their potential role in improving mental health has been heating up for a while. Now, with the signing of an executive order for the FDA to fast track review of these drugs, interest is at a fever pitch. This order is expected to lower barriers to researching these drugs and may even make some drugs eligible for the Right to Try Act. A decade ago, using drugs like magic mushrooms, especially in a therapist’s office, seemed cringey, extreme, and not helpful for what patients were there for. Today…it’s complicated. Tech bros and CEOs have been trumpeting their use of mushrooms (psilocybin) to optimize performance and improve emotional well-being, and new science is probing the mental health benefits of these and other psychedelics.…